A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants

作者：Tao Sha; Wang Zhong; Feng Junjie; Hsu Fang Chi; Jin Guangfu; Kim Seong Tae; Zhang Zheng; Gronberg Henrik; Zheng Lilly S; Isaacs William B; Xu Jianfeng; Sun Jielin^*

来源：Carcinogenesis, 2012, 33(3): 598-603.

DOI：10.1093/carcin/bgr316

Genome-wide association studies (GWAS) have identified similar to 30 single-nucleotide polymorphisms (SNPs) consistently associated with prostate cancer (PCa) risk. To test the hypothesis that other sequence variants in the genome may interact with those 32 known PCa risk-associated SNPs identified from GWAS to affect PCa risk, we performed a systematic evaluation among three existing PCa GWAS populations: CAncer of the Prostate in Sweden population, a Johns Hopkins Hospital population, and the Cancer Genetic Markers of Susceptibility population, with a total sample size of 4723 PCa cases and 4792 control subjects. Meta-analysis of the interaction term between each of those 32 SNPs and SNPs in the genome was performed in three PCa GWAS populations. The most significant interaction detected was between rs12418451 in MYEOV and rs784411 in CEP152, with a P-interaction of 1.15 x 10(-7) in the meta-analysis. In addition, we emphasized two pairs of interactions with potential biological implication, including an interaction between rs7127900 near insulin-like growth factor-2 (IGF2)/IGF2AS and rs12628051 in TNRC6B, with a P-interaction of 3.39 x 10(-6) and an interaction between rs7679763 near TET2 and rs290258 in SYK, with a P-interaction of 1.49 x 10(-6). Those results show statistical evidence for novel loci interacting with known risk-associated SNPs to modify PCa risk. The interacting loci identified provide hints on the underlying molecular mechanism of the associations with PCa risk for the known risk-associated SNPs. Additional studies are warranted to further confirm the interaction effects detected in this study.

• 出版日期2012-3